Loading data for AMRX — first visit, this takes a few seconds.
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS: AMRX
· Real-Time Price · USD
17.68
+0.21 (1.20%)
At close: Sep 01, 2026, 8:00 PM
17.68
+0.00%
After-hours: 4:20 PM
The price, the headline numbers and the latest news, in one place.
Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, Analysis & Data
No data available
| Bid | 12.68 |
| Market Cap | 6.16B |
| Revenue (ttm) | 3.12B |
| Net Income (ttm) | 157M |
| 1.25 | |
| 0.48 | |
| 36.83 | |
| 15.23 | |
| P/B (ttm) | 171.65 |
| P/S (ttm) | 1.98 |
| Earnings Date | May 4, 2026 |
| Ask | 22.47 |
| Volume | 1,353,613 |
| Avg. Volume (20D) | 1,981,942 |
| Open | 17.57 |
| Previous Close | 17.47 |
| Day's Range | 17.49 - 17.99 |
| 52-Week Range | 9.32 - 19.26 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AMRX
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and e...
Sector Healthcare
IPO Date May 7, 2018
Employees 8,700
Stock Exchange NasdaqGS
Ticker Symbol AMRX
Website https://www.amneal.com
Financial Performance
In 2025, Amneal Pharmaceuticals's revenue was 3.02B, an increase of 8.05% compared to the previous year's 2.79B. Earnings were 72.06M, a decrease of -161.65%.
Financial StatementsEarnings Surprise
Amneal Pharmaceuticals has released their quarterly earnings on Jul 30, 2026:
- Revenue of $796.2M misses estimates by $0, with 9.89% YoY growth.
- EPS of 0.3 exceeds estimates by 0.07, with 20.00% YoY growth.
Amneal Pharmaceuticals, Inc. is scheduled to release its earnings on May 4, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2


